What is IDx-DR
IDx-DR is the world first FDA De Novo authorized autonomous AI diagnostic system, detecting diabetic retinopathy from fundus photographs without requiring physician interpretation.
Autonomous Diagnosis
IDx-DR provides diagnostic output autonomously enabling deployment in primary care settings where ophthalmologists are not available, making screening accessible to 537 million diabetic patients worldwide.
Clinical Validation
FDA pivotal trial achieved 87.2 percent sensitivity and 90.7 percent specificity across over 900 patients at 10 primary care sites.
MedicalCloudAIHub Integration
MedicalCloudAIHub routes fundus photography studies to IDx-DR with results automatically converted to structured FHIR DiagnosticReport resources.